Homeopathy

PreclinicalSmall molecule

NNMP Medical Research Institute

Homeopathy is one of 15 small molecule programs targeting Menorrhagia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MenorrhagiaActive, not recruiting

MenorrhagiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

18 competitors in Menorrhagia

#DrugCompanyPhaseTrials

Cyklokapron

AAmring

Approved

5 2

Cytotec

Danocrine

Jadelle

IItalian Network for Tumor Biotherapy Foundation

Approved

2 5

Orgovyx

Sumitomo Pharma America, Inc.

Depo-Provera

1 7

Levonorgestrel IUS

Bayer

Phase 3

2 8

Diosmin

TTanta University

Phase 2

1 9

Asoprisnil

Bayer

Phase 2

1 10

Estradiol Valerate

Bayer

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Menorrhagia1 trial

Trial of Homeopathy on Management of Menorrhagia

Completed·NNMP Medical Research Institute·N/A·NCT01460043·25 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Homeopathy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Homeopathy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Homeopathy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — NMP Medical Research Institute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNMP Medical Research Institute

Homeopathy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Menorrhagia1 trial

References

Drug Info

Quick Facts

Related News